Ronald B. Kocak
Chief Accounting Officer
RenovoRx, Inc. (RNXT)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Ronald B. Kocak
Ronald B. Kocak is recorded as Chief Accounting Officer at RenovoRx, Inc. (RNXT). RenovoRx, Inc. reported in an 8-K filed February 6, 2026 that Ronald B. Kocak resigned as Principal Accounting Officer, effective February 3, 2026. RenovoRx, Inc. reported in an 8-K filed February 9, 2024 that Ronald B. Kocak was appointed Vice President, Controller and Principal Accounting Officer, effective February 8, 2024. The proxy statement of RenovoRx, Inc. reports total compensation of $616,696 for Ronald B. Kocak in fiscal 2025, including a base salary of $346,097.
“On February 3, 2026, Ronald B. Kocak notified the board of directors (the "Board") of RenovoRx, Inc., a Delaware corporation (the "Company"), his intent to resign from his position as Principal Accounting Officer of the Company, effective as of the close of business on February 3, 2026.”
“On February 8, 2024, the Company's board of directors (the "Board"), at the recommendation of the audit and compensation committees of the Board, appointed Ronald B. Kocak, CPA, CGMA, the Company's current Vice President and Controller, to the position of Vice President, Controller and Principal Accounting Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-02-08–present
-
2024-02-08–2026-02-03
-
RenovoRx, Inc. (RNXT)
Proxy statement
Start not stated–2025-04-30
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at RenovoRx, Inc.
Other people whose current roles at this company are on record from its filings.
- Shaun Bagai CEO, Board Member
- Shaun R. Bagai CEO, Board Member
- Ramtin Agah Chairman
- Ramtin Agah, M.D. Chairman
- James Ahlers CFO
- Mark Voll CFO
- Angela Gill Nelms COO
- Kirsten Angela Macfarlane Board Member
- Laurence J. Marton Board Member
- Laurence J. Marton, M.D. Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | RenovoRx, Inc. (RNXT) | Vice President, Controller and Principal Accounting Officer | $346,097 | $616,696 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.